Results 101 to 110 of about 20,609,879 (370)

Custom v. Standardized Risk Models [PDF]

open access: yesRisks 3(2) (2015) 112-138, 2014
We discuss when and why custom multi-factor risk models are warranted and give source code for computing some risk factors. Pension/mutual funds do not require customization but standardization. However, using standardized risk models in quant trading with much shorter holding horizons is suboptimal: 1) longer horizon risk factors (value, growth, etc.)
arxiv  

Assessment of intervention measures on trihalomethane in finished water by interrupted time series analysis

open access: yes环境与职业医学
BackgroundThe Qingcaosha Reservoir is facing issues of algal blooms and eutrophication, and the resulting increase in the level of chlorination disinfection by-products in the water has been a major concern.
Yangyang REN   +8 more
doaj   +1 more source

GLOBAL RISK FACTORS

open access: yesJournal of Business Economics and Management, 2006
The paper deals with a problem of solar and geomagnetic activity as global risk factors in financial risk management. The history of the idea of solar – earth relations is rather long (Hershel, 1804; Jevans, 1870 – Theory of Solar cycles, Chizhevsky, 1920 ‐ Theory of Heliotaraxy; Collins, 1965 etc.), but financial risk management does not use these ...
openaire   +4 more sources

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

Epidemiological characteristics of and risk factors for breast cancer in the world

open access: yesBreast Cancer, 2019
Aim Breast cancer is the most common cancer among women and one of the most important causes of death among them. This review aimed to investigate the incidence and mortality rates of breast cancer and to identify the risk factors for breast cancer in ...
Z. Momenimovahed, H. Salehiniya
semanticscholar   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Research progress on ultra-processed foods consumption and its association with health

open access: yes环境与职业医学
With the rapid progress of industrialization and commercialization, the sales and population intake of ultra-processed foods (UPFs) are constantly increasing globally. High UPFs intake is associated with various health issues.
Jiaqian ZHONG   +4 more
doaj   +1 more source

Portal Vein Thrombosis

open access: yes, 2021
M. Vivarelli   +2 more
semanticscholar   +1 more source

Alzheimer’s disease: risk factors and potentially protective measures

open access: yesJournal of Biomedical Sciences, 2019
Alzheimer’s disease (AD) is the most common type of dementia and typically manifests through a progressive loss of episodic memory and cognitive function, subsequently causing language and visuospatial skills deficiencies, which are often accompanied by ...
M. Silva   +5 more
semanticscholar   +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

open access: yesMolecular Oncology, EarlyView.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy